Hypertension Diagnostics (HDII) Stock Statistics & Valuation Metrics
Total Valuation
Hypertension Diagnostics has a market cap or net worth of $285.00. The enterprise value is $13.68B.
- Market Cap
- $285.00
- Enterprise Value
- $13.68B
Share Statistics
Hypertension Diagnostics has 284,781,620 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 284,781,620
- Owned by Insiders
- ―
- Owned by Institutions
- 0.02%
Financial Efficiency
Hypertension Diagnostics’s return on equity (ROE) is 0.76 and return on invested capital (ROIC) is 100.00%.
- Return on Equity (ROE)
- 0.76
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- 100.00%
- Return on Capital Employed (ROCE)
- 1.00
- Revenue Per Employee
- 0
- Profits Per Employee
- -31.08K
- Employee Count
- 3
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Hypertension Diagnostics is -0.25. Hypertension Diagnostics’s PEG ratio is -0.00.
- PE Ratio
- -0.25
- PS Ratio
- 0.00
- PB Ratio
- -0.17
- Price to FCF
- -0.02
- Price to Operating Cash Flow
- -0.02
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Hypertension Diagnostics had revenue of 0 and earned -93.25K in profits. Earnings per share was 0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -121.89K
- Pretax Income
- -93.25K
- Net Income
- -93.25K
- EBITDA
- 135.24K
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was -11.00K and capital expenditures 0, giving a free cash flow of -11.00K billion.
- Operating Cash Flow
- -11.00K
- Free Cash Flow
- -11.00K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Hypertension Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -6521.87%
- Earnings Yield
- -437.60%
Stock Price Statistics
- Beta
- -20.63
- 52-Week Price Change
- -52.38%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Hypertension Diagnostics as a current ratio of 0.00, with Debt / Equity ratio of 0.00%
- Current Ratio
- 0.00
- Quick Ratio
- 0.00
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.00
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Hypertension Diagnostics has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Hypertension Diagnostics EV to EBITDA ratio is 0.10, with an EV/FCF ratio of -0.02.
- EV to Sales
- 0.00
- EV to EBITDA
- 0.10
- EV to Free Cash Flow
- -0.02
- EV to Operating Cash Flow
- -0.02
Balance Sheet
Hypertension Diagnostics has $86.39K in cash and marketable securities with $651.32K in debt, giving a net cash position of -$564.93K billion.
- Cash & Marketable Securities
- $86.39K
- Total Debt
- $651.32K
- Net Cash
- -$564.93K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- -$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Hypertension Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
